An observational study in Aplastic Anemia and Healthy, sponsored by Shandong University. Withdrawn at 1 site in China. Open to participants aged 16 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-20.
Sponsored by Shandong University · Observational
This study is designed to collect bone marrow and/or peripheral blood cells and plasma, for the analysis of adhesion molecules, chemokines and their receptors from newly-diagnosed aplastic anemia patients, and patients treated with antithymocyte globulin plus cyclosporine
1,733 studies on the registry are indexed under Anemia; 246 are open to participants now.
Browse Anemia studies →Shandong University is the lead sponsor of 284 studies on the registry; 59 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients With Aplastic Anemia
Exclusion Criteria:
Acquired Aplastic Anemia Patients Treated with Antithymocyte Globulin plus Cyclosporine
hematologic response
hematologic response at 6 months following antithymocyte globulin plus cyclosporine treatment, defined as no longer meeting the criteria for severe aplastic anemia
Time frame: 6 months following antithymocyte globulin plus cyclosporine treatment
This study is withdrawn, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shandong University